Name
Sõle Loomakliinik OÜ
Registry code
14374419
VAT number
EE102036309
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
20.11.2017 (6)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
75001 - Veterinary activities
290 149 €
65 949 €
23%
2 760 €
(estimate is approximate)
255 938 €
2
Submitted
No tax arrears
26%
23%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Peeter Kesner 10.10.1958 (66) | 60% - 1 500.00 EUR | Board member | Direct ownership | |
Merili Kesner 30.04.1982 (42) | 40% - 1 000.00 EUR | Board member | Direct ownership | Founder |
osaühing Valgushelk 10359937 | - | - | - | Founder |
Ketlin Sõstra 30.01.1988 (36) | - | - | - | Founder |
2019 26.04.2020 | 2020 21.05.2021 | 2021 16.03.2022 | 2022 18.04.2023 | 2023 27.03.2024 | |
---|---|---|---|---|---|
Total Revenue | 211 427 € | 266 338 € | 274 400 € | 299 784 € | 290 149 € |
Net profit (loss) for the period | 65 948 € | 82 272 € | 62 504 € | 62 369 € | 65 949 € |
Profit Margin | 31% | 31% | 23% | 21% | 23% |
Current Assets | 75 756 € | 138 580 € | 186 634 € | 205 584 € | 275 676 € |
Fixed Assets | 38 131 € | 24 067 € | 19 927 € | 16 240 € | 9 179 € |
Total Assets | 113 887 € | 162 647 € | 206 561 € | 221 824 € | 284 855 € |
Current Liabilities | 31 059 € | 22 547 € | 28 941 € | 31 835 € | 28 917 € |
Non Current Liabilities | - | - | - | - | - |
Total Liabilities | - | - | - | - | - |
Share Capital | - | - | - | - | - |
Equity | 82 828 € | 140 100 € | 177 620 € | 189 989 € | 255 938 € |
Employees | 3 | 3 | 3 | 3 | 2 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | 62 567.32 € | 16 478.97 € | 9 777.97 € | 3 |
2023 Q4 | 71 667.71 € | 16 924.97 € | 8 672.1 € | 3 |
2023 Q3 | 74 865.51 € | 16 678.52 € | 8 290.3 € | 3 |
2023 Q2 | 80 450.93 € | 15 986.32 € | 7 031.9 € | 3 |
2023 Q1 | 64 228.05 € | 14 043.38 € | 8 850.84 € | 4 |
2022 Q4 | 78 347.2 € | 18 039.35 € | 8 786.46 € | 3 |
2022 Q3 | 78 115.94 € | 28 224.11 € | 8 571.56 € | 3 |
2022 Q2 | 78 055.31 € | 16 527.63 € | 7 521.26 € | 3 |
2022 Q1 | 66 662.89 € | 17 555.95 € | 9 643.13 € | 3 |
2021 Q4 | 74 981.35 € | 16 228.92 € | 7 404.2 € | 3 |
2021 Q3 | 70 598.54 € | 19 814.31 € | 7 884.52 € | 3 |
2021 Q2 | 68 653.72 € | 13 970.74 € | 6 133 € | 3 |
2021 Q1 | 60 242.27 € | 15 130.28 € | 5 669.26 € | 3 |
2020 Q4 | 67 818.57 € | 12 836.66 € | 4 818.77 € | 3 |
2020 Q3 | 69 650.72 € | 12 866.03 € | 4 616.4 € | 3 |
2020 Q2 | 63 843.09 € | 15 923.54 € | 4 614.42 € | 3 |
2020 Q1 | 60 777.26 € | 10 573.1 € | 4 217.38 € | 3 |